![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 36 36" xmlns="http://www.w3.org/2000/svg"><path d="M 19 18 L 36 18 L 36 19 L 19 19 L 19 36 L 18 36 L 18 19 L 0 19 L 0 18 L 18 18 L 18 0 L 19 0 Z" fill="rgb(255, 255, 255)" height="36px" id="zGS8DWzeh" width="36px"/></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 36 36" xmlns="http://www.w3.org/2000/svg"><path d="M 19 18 L 36 18 L 36 19 L 19 19 L 19 36 L 18 36 L 18 19 L 0 19 L 0 18 L 18 18 L 18 0 L 19 0 Z" fill="rgb(255, 255, 255)" height="36px" id="SCKJPsPDW" width="36px"/></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 575 575" xmlns="http://www.w3.org/2000/svg"><path d="M 287.5 575 C 446.282 575 575 446.282 575 287.5 C 575 128.718 446.282 0 287.5 0 C 128.718 0 0 128.718 0 287.5" fill="transparent" height="575px" id="XINTwJ_kr" stroke-dasharray="2,6" stroke-linecap="round" stroke-linejoin="round" stroke-width="1" stroke="rgb(255, 255, 255)" width="575px"/></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 437 437" xmlns="http://www.w3.org/2000/svg"><path d="M 437 218.5 C 437 97.826 339.174 0 218.5 0 C 97.826 0 0 97.826 0 218.5 C 0 339.174 97.826 437 218.5 437" fill="transparent" height="437px" id="x4TBJrhbE" stroke-dasharray="2,6" stroke-linecap="round" stroke-linejoin="round" stroke-width="1" stroke="rgb(255, 255, 255)" width="437px"/></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 353 705" xmlns="http://www.w3.org/2000/svg"><path d="M 0 705 C 194.68 705 352.5 547.18 352.5 352.5 C 352.5 157.82 194.68 0 0 0" fill="transparent" height="705px" id="i3oYFU0c2" stroke-dasharray="2,6" stroke-linecap="round" stroke-linejoin="round" stroke-width="1" stroke="rgb(255, 255, 255)" width="352.5px"/></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 2884 1" xmlns="http://www.w3.org/2000/svg"><path d="M 1442 0 L 0 0" fill="rgb(255, 255, 255)" height="1px" id="Sh6EUmXq2" stroke-dasharray="2,6" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="1" stroke="rgb(255, 255, 255)" transform="translate(0 0.5)" width="1442px"/><path d="M 1442 0 L 0 0" fill="rgb(255, 255, 255)" height="1px" id="uUTlaGEFM" stroke-dasharray="2,6" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="1" stroke="rgb(255, 255, 255)" transform="translate(1440 0.5)" width="1442px"/></svg>)
![](data:image/svg+xml,<svg display="block" role="presentation" viewBox="0 0 1 900" xmlns="http://www.w3.org/2000/svg"><path d="M 0 0 L 0 900" fill="transparent" height="900px" id="n9VS7prGc" stroke-dasharray="2,6" stroke-linecap="butt" stroke-linejoin="miter" stroke-miterlimit="10" stroke-width="1" stroke="rgb(255, 255, 255)" transform="translate(0.5 0)" width="1px"/></svg>)
Microdosed semaglutide uses the same GLP-1 receptor agonist at calibrated lower doses, compounded with supporting ingredients selected by your clinician. It's designed to support metabolic health and appetite regulation at a maintenance level. Not an aggressive titration.
Physician monitored
Low-dose, physician guided
Ongoing maintenance
Physician guided subcutaneous injection
Medication, clinician, follow-ups
What you
can expect
A LOW-DOSE PROTOCOL BUILT TO HOLD THE RESULT
GUIDED LOWER
DOSE PROTOCOL
Your clinician calibrates your dose around your metabolic profile and your goals. Starting low. Adjusting based on how your body responds. The lowest effective dose is the point.
SUPPORTS APPETITE
REGULATION
Designed to help normalize hunger signals without aggressive suppression. The food noise quiets at a maintenance level. Your body finds its natural rhythm
SUPPORTS
METABOLIC HEALTH
Research suggests even lower doses of GLP-1 agonists may help sustain improvements in insulin sensitivity and other metabolic markers. Individual results vary.
ONE SIZE FITS NONE
Personalized protocols, tuned to your body.
Dr. Jonathann Kuo, MD
A maintenance protocol is a different conversation than a titration. For the right patient, it's the tool that keeps the result holding.
MY STORY
Oliver Woloshin, 47
I had a great experience with Enhanced Games from start to finish. The onboarding process was smooth and straightforward, and I was able to get my first order quickly without any issues.
YOU'RE NOT TRYING TO LOSE 40 POUNDS. YOU'RE TRYING TO STAY EXACTLY WHERE YOU ARE.
A low-dose GLP-1 protocol is clinician-prescribed and designed to support appetite regulation and metabolic function in a sustainable maintenance zone. Your protocol is personalized to your goals and adjusted to your response. Individual results vary.
*Available by prescription only, if medically appropriate.
